Share This Author
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- J. Smolen, R. Landewé, D. M. van der Heijde
- MedicineAnnals of the rheumatic diseases
- 25 October 2013
TLDR
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
- J. Smolen, R. Landewé, D. M. van der Heijde
- MedicineAnnals of the rheumatic diseases
- 1 June 2010
TLDR
Genetics of rheumatoid arthritis contributes to biology and drug discovery
TLDR
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- J. Smolen, R. Landewé, D. M. van der Heijde
- MedicineAnnals of the Rheumatic Diseases
- 22 January 2020
TLDR
EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome
TLDR
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International…
- C. Shiboski, S. Shiboski, X. Mariette
- MedicineArthritis & rheumatology
- 1 January 2017
To develop and validate an international set of classification criteria for primary Sjögren's syndrome (SS) using guidelines from the American College of Rheumatology (ACR) and the European League…
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.
- O. Hermine, F. Lefrère, X. Troussard
- MedicineThe New England journal of medicine
- 11 July 2002
TLDR
EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome
TLDR
Advances in understanding the pathogenesis of primary Sjögren's syndrome
- G. Nocturne, X. Mariette
- Biology, MedicineNature Reviews Rheumatology
- 16 July 2013
TLDR
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.
- K. Fizazi, A. Lipton, S. Jun
- Medicine, BiologyJournal of clinical oncology : official journal…
- 1 April 2009
TLDR
...
...